Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PTCT
PTCT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PTCT News
PTC Therapeutics Approves Employee Stock Options
3d ago
PRnewswire
PTC Therapeutics Grants Stock Options to New Employees
3d ago
Newsfilter
PTC Therapeutics Prices $500M Convertible Notes Offering
4d ago
seekingalpha
PTC Therapeutics Prices $500 Million Convertible Notes Offering
4d ago
NASDAQ.COM
PTC Therapeutics Prices $500 Million Convertible Notes Offering
4d ago
PRnewswire
PTC Therapeutics Prices $500 Million Convertible Notes Offering
4d ago
Newsfilter
PTC Therapeutics Plans $500 Million Convertible Notes Offering
5d ago
PRnewswire
Wall Street Analysts Weekly Recap: Crocs, PTC, Oscar, General Dynamics
6d ago
Yahoo Finance
PTC Therapeutics Stock Upgraded by Jefferies Amid Positive Outlook
May 27 2026
seekingalpha
Healthcare Stocks Decline Late Friday Afternoon
May 08 2026
Yahoo Finance
PTC Therapeutics Raises Full-Year Outlook Amid Strong Sephience Launch
May 08 2026
seekingalpha
PTC Therapeutics Reports Record Q1 2026 Earnings with Raised Guidance
May 08 2026
seekingalpha
PTC Therapeutics Reveals Long-Term Results for Votoplam in Huntington's Disease
Apr 28 2026
NASDAQ.COM
PTC and Novartis Advance Huntington's Disease Research with Votoplam
Apr 28 2026
PRnewswire
PTC and Novartis Announce Votoplam Study Progress
Apr 28 2026
Newsfilter
PTC Therapeutics Approves Stock Options and RSUs for New Hire
Apr 17 2026
PRnewswire
Show More News
